drugset / Trial / NCT03509883
Bioavailability of Apixaban Sprinkle Compared to Apixaban Capsules
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the absorption of apixaban (BMS-562247) into the bloodstream of healthy volunteers, when administered as sprinkle capsules compared to tablets. Eligible participants will be randomly assigned to 1 of 2 treatment sequences and will receive a single oral dose of apixaban twice during the course of the study.
Timeline
- Start
- 2018-04-26
- Primary completion
- 2018-06-15
- Completion
- 2018-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apixaban | Small molecule | 2.5 mg | Oral |
Indications
No indication recorded.